Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors (Q34363866)
scientific article published on September 27, 2010
Language:
(P31) (Q13442814)
(P50) (Q78004526)
(P304) 2049-2057
(P407) (Q1860)
(P433) 12
(P478) 31
(P577) Monday, September 27, 2010
(P921) (Q14863436)
(P953) https://academic.oup.com/carcin/article-pdf/31/12/2049/17287735/bgq192.pdf
http://carcin.oxfordjournals.org/cgi/content/abstract/31/12/2049
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20876285/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20876285/pdf/?tool=EBI
https://europepmc.org/articles/PMC2994280
https://europepmc.org/articles/PMC2994280?pdf=render
http://academic.oup.com/carcin/article-pdf/31/12/2049/17287735/bgq192.pdf
(P1433) (Q326022)
(P1476) "Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors" (language: en)
"Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors" (language: en)
(P2093) Partha M. Das
Virgilio A. Salvo
Juan P. Fonseca
Matthew E. Burow
Frank E. Jones
(P2860) (Q39813863)
(Q24649539)
(Q24635408)
(Q28297958)
(Q24645663)
(Q24648241)
(Q36881741)
(Q28278471)
(Q37151040)
(Q37095827)
(Q34745057)
(Q29617352)
(Q24337209)
(Q40198718)
(Q29616149)
(Q40219136)
(Q40243239)
(Q40243337)
(Q24293729)
(Q27860773)
(Q36328588)
(Q24536069)
(Q36065443)
(Q40614262)
(Q34181456)
(Q34398439)
(Q28594099)
(Q33890758)
(Q28283241)
(Q29619251)
(Q42807740)
(Q41335122)
(Q42824817)
(Q52573864)
(Q46144659)
(Q54031538)
(Q73121475)
(Q79696543)
other details
description scientific article published on September 27, 2010

External Links